Not Yet Recruiting EARLY_PHASE1 INTERVENTIONAL 4-arm NCT07214974

Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device. (MCITestCare)

Mild Cognitive Impairment Community Screening, Early Detection, and Therapeutic Intervention to Slow Down, or Stop the Progression of the Cognitive Impairment.

Sponsor: Noah Tech, Corp.

Conditions Alzheimer's Disease Dementia Alzheimer's Disease Diagnosis Alzheimer's Disease and Related Dementias Dementia (Diagnosis) Dementia MCI (Mild Cognitive Impairment) Early Stages of Cognitive Decline Mild Cognitive Impairment (MCI) Parkinson's Disease Parkinson's Disease (PD) Parkinson's Disease With Wearing-off Motor Fluctuations

Interventions Control - Placebo Comparator Stem Cell Therapy - Experimental Structured wellness care Wearable brain-computer interface devices

Updated 2 times since 2025 Last updated: Mar 6, 2026 Started: Sep 1, 2026 Primary completion: Sep 30, 2029 Completion: Jan 3, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Alzheimer's Disease Dementia and Alzheimer's Disease Diagnosis, this trial is actively recruiting participants. The trial is conducted by Noah Tech, Corp. and has accumulated 2 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

2 versions recorded

Mar 2026 — Present [monthly]

Not Yet Recruiting EARLY_PHASE1
Nov 2025 — Mar 2026 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Noah Tech, Corp.

Data source: Noah Tech, Corp.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Palisades Park, United States